New advancements in GLP-1 receptor agonist are focusing on novel delivery methods, in particular the development of quickly dissolving pills. These new formats seek to increase user convenience and potentially present more rapid uptake, resulting to improved clinical effects. Experts hypothesize that this approach holds significant promise for the